My watch list
my.bionity.com  
Login  

Pseudo-Hurler polydystrophy



Pseudo-Hurler polydystrophy
Classification & external resources
ICD-10 E77.0
ICD-9 272.7
OMIM 252600
DiseasesDB 29378
MeSH D009081

Pseudo-Hurler polydystrophy, also referred to as mucolipidosis III (ML III), is lysosomal storage disease closely related to I-cell disease (ML II). Symptoms of ML III are often not noticed until the child is 3-5 years of age.

Additional recommended knowledge

Contents

Pathophysiology

As in ML II, ML III results from genetic defects in GlcNAc phosphotransferase (N-acetylglucosamine-1-phosphotransferase). However, ML III produces less severe symptoms and progresses more slowly, probably because the defect in GlcNAc phosphotranspherase lies in its protein recognition domain.[1] Therefore, the catalytic domain retains some of its activity, resulting in a smaller accumulation of carbohydrates, lipids, and proteins in the inclusion bodies.

Presentation

Patients with ML III are generally of normal intelligence (trait) or have only mild mental retardation. These patients usually have skeletal abnormalities, coarse facial features, short height, and corneal clouding. Some individuals with ML III survive until their fourth or fifth decade of life.

References

  1. ^ Murray, R, Granner, D, and Rodwell, V. (2006). Harper's Illustrated Biochemistry. 27th ed. New York: Lange Medical Books/McGraw-Hill.
  • mucolipidoses at NINDS - original text of article derived from detail sheet available here

See also

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pseudo-Hurler_polydystrophy". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE